Published in Metabolism on August 03, 2011
Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One (2012) 1.38
Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci (2013) 1.21
Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs. Age (Dordr) (2014) 1.12
Metabolic inflexibility during submaximal aerobic exercise is associated with glucose intolerance in obese older adults. Obesity (Silver Spring) (2013) 0.90
Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab (2013) 0.89
DNA methylation pattern in overweight women under an energy-restricted diet supplemented with fish oil. Biomed Res Int (2014) 0.88
The role of pyruvate dehydrogenase kinase in diabetes and obesity. Diabetes Metab J (2014) 0.86
A minimal dose of electrically induced muscle activity regulates distinct gene signaling pathways in humans with spinal cord injury. PLoS One (2014) 0.82
Associations between whole peripheral blood fatty acids and DNA methylation in humans. Sci Rep (2016) 0.79
Increased pyruvate dehydrogenase kinase expression in cultured myotubes from obese and diabetic individuals. Eur J Nutr (2014) 0.79
Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance. J Appl Physiol (1985) (2013) 0.77
Integrated analysis of chronic lipotoxicity on muscle metabolism and stress and its reversal by antioxidants. Springerplus (2014) 0.77
Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells. Hypoxia (Auckl) (2016) 0.75
Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy. J Biol Chem (2016) 0.75
Inhibition of neutral sphingomyelinases in skeletal muscle attenuates fatty-acid induced defects in metabolism and stress. Springerplus (2014) 0.75
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism. PLoS One (2017) 0.75
DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome. PLoS One (2017) 0.75
Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem (2003) 3.45
AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest (2006) 3.39
TXNIP regulates peripheral glucose metabolism in humans. PLoS Med (2007) 3.27
Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab (2009) 2.76
Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab (2013) 2.47
Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab (2012) 2.46
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes (2005) 2.35
Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet (2008) 2.14
Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle. Diabetes (2008) 2.03
Glutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 2.01
Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res (2003) 2.01
Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell (2008) 1.97
The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem (2004) 1.94
T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res (2009) 1.93
Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes (2005) 1.89
AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes (2006) 1.85
ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth. PLoS Biol (2009) 1.61
Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise. Am J Physiol Endocrinol Metab (2004) 1.58
Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J (2005) 1.55
MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. J Biol Chem (2007) 1.53
Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem (2003) 1.53
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab (2006) 1.48
Strenuous physical exercise adversely affects monocyte chemotaxis. Thromb Haemost (2010) 1.45
5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes (2003) 1.45
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol (2006) 1.43
Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem (2007) 1.40
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes (2007) 1.37
Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle. Diabetes (2006) 1.37
Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am J Physiol Endocrinol Metab (2003) 1.32
Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep (2013) 1.31
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev (2011) 1.30
Changes in exercise-induced gene expression in 5'-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice. Diabetes (2005) 1.29
Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes (2005) 1.28
Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J (2002) 1.28
Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev (2009) 1.27
Insulin-stimulated phosphorylation of the Rab GTPase-activating protein TBC1D1 regulates GLUT4 translocation. J Biol Chem (2009) 1.27
Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res (2008) 1.24
Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes (2006) 1.19
Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. Am J Physiol Endocrinol Metab (2012) 1.19
Calcineurin regulates skeletal muscle metabolism via coordinated changes in gene expression. J Biol Chem (2006) 1.18
Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem (2008) 1.17
MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol (2004) 1.16
Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol (2013) 1.16
Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc (2004) 1.15
Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003) 1.13
DNA methylation in metabolic disorders. Am J Clin Nutr (2011) 1.11
Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev (2006) 1.11
Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. Diabetes (2005) 1.10
IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients. Diabetes (2006) 1.10
Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health care centres. Scand J Prim Health Care (2004) 1.10
Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem Biophys (2007) 1.10
5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J (2005) 1.09
Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab (2004) 1.08
Xbves is a regulator of epithelial movement during early Xenopus laevis development. Proc Natl Acad Sci U S A (2006) 1.08
Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Curr Diabetes Rev (2005) 1.06
Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology (2008) 1.05
Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol (2012) 1.04
The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab (2012) 1.02
Insulin signaling defects in type 2 diabetes. Rev Endocr Metab Disord (2004) 1.02
siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. Diabetes (2008) 1.02
Kinetics of GLUT4 trafficking in rat and human skeletal muscle. Diabetes (2009) 1.01
ERK1/2 mediates insulin stimulation of Na(+),K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. J Biol Chem (2004) 1.00
Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice. J Biol Chem (2006) 0.99
Exercise-induced mitogen-activated protein kinase signalling in skeletal muscle. Proc Nutr Soc (2004) 0.99
Isoform-specific regulation of 5' AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes (2002) 0.99
Relationship between AMPK and the transcriptional balance of clock-related genes in skeletal muscle. Am J Physiol Endocrinol Metab (2008) 0.99
Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes (2012) 0.98
Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab (2013) 0.97
Exercise and the treatment of diabetes and obesity. Med Clin North Am (2011) 0.96
Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One (2013) 0.96
The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells. Mol Immunol (2010) 0.95